Avacta Group reported a marginal rise in group revenue to £24.42m, with diagnostics division sales increasing by 14.7%. However, therapeutics revenue fell to £0.11m due to the absence of milestones from AffyXell. Avacta continues to expand its clinical and research activities, advancing its lead preCISION programme AVA6000 into phase 1b trials across multiple cancers. The […]
Tag: Oncology
Exploring Amgen’s Market Sentiment Through Options Trading
Imagine a painter who, with a masterful stroke of her brush, brings to life a vivid panorama. Now, replace that painter with Amgen, a leading biotechnology company, and the canvas with the landscape of human therapeutics. The paints? Innovations like Epogen, Neulasta, Enbrel, and Vectibix, each a vibrant hue in the spectrum of Amgen’s diverse […]
AI’s Impact on Precision Oncology by 2025
The advent of the information era has ushered in an unprecedented revolution in many fields, with the healthcare sector being no exception to this. In the realm of precision oncology, the latest protagonist is Generative AI, a technology possessing computational capabilities so powerful that they are reshaping the landscape of cancer therapeutics. It is a […]
Revolutionizing Personalized Cancer Treatment with 3D Bioprinting: The Future of Oncology
The landscape of cancer treatment is undergoing profound change driven by innovative technologies. Among these, 3D bioprinting emerges as a revolutionary tool poised to redefine personalized medicine, particularly in oncology. This blog post explores how 3D bioprinted cancer models can accelerate the development of personalized therapies and how this advancement aligns with broader trends in […]
